Skip to main content
. Author manuscript; available in PMC: 2007 Jul 9.
Published in final edited form as: J Comp Neurol. 2005 Mar 21;483(4):458–475. doi: 10.1002/cne.20437

TABLE 1.

Calretinin Immunostaining in AVCN, PVCN, and DCN in Control (N = 3) and Ablated (N = 8) Animals1

Left side (contralateral)
 Right side (ipsilateral)
Nucleus
mean gray
level		 Mean gray
level within
neurons		 Neuron
immunostained
area (μm2)		 Nucleus
mean gray level		 Mean gray
level within
neurons		 Neuron
immunostained
area (μm2)
Control
 AVCN   1.62 ± 0.07 1.76 ± 0.06 171.39 ± 6.56(**) 1.62 ± 0.04(**) 1.76 ± 0.08 171.58 ± 1.33(**)
 PVCN 1.60 ± 0.06 1.74 ± 0.06 177.43 ± 4.51(**)   1.60 ± 0.09(**) 1.76 ± 0.07 176.66 ± 4.53(**)
 DCN 1.25 ± 0.06 1.75 ± 0.06  53.85 ± 4.43 1.26 ± 0.05   1.75 ± 0.06  54.98 ± 6.45
Ablated
 AVCN 1.77 ± 0.08(*) 1.80 ± 0.01 184.62 ± 4.54(*)(**) 1.28 ± 0.13(*)(**)   1.83 ± 0.02 146.77 ± 7.39(*)(**)
 PVCN 1.65 ± 0.09(*) 1.80 ± 0.01 191.01 ± 7.23(*)(**) 1.03 ± 0.22(*)(**)   1.83 ± 0.02 151.13 ± 8.64(*)(**)
 DCN 1.29 ± 0.16 1.79 ± 0.02  57.56 ± 4.79 1.28 ± 0.19   1.80 ± 0.02  54.95 ± 7.15
1

Values expressed are means and standard deviations.

(*)

indicates significant differences between sides

(**)

indicates significant differences between groups; AVCN, anteroventral; DCN, dorsal cochlear nucleus; PVCN, posteroventral.